Diagnostics

Companies team up to provide hs-CRP test for clinical trial recruitment and screenings

Published in Blood Weekly, November 10th, 2005

Cholestech Corp. (CTEC), a manufacturer of point of care testing devices, announced that it is partnering with AstraZeneca (AZN), a pharmaceutical company.

Cholestech is providing a high sensitivity C-Reactive Protein (hs-CRP) test for the Cholestech LDXSystem to rapidly prescreen patients for eligibility to participate in a global multisite clinical study, sponsored by AstraZeneca.

"We know that individuals with increased blood levels of hs-CRP are at high risk for heart attack and stroke, even if they have normal cholesterol levels," said Dr. Paul Ridker, a cardiologist at the Brigham and Women's Hospital in Boston, Massachusetts, and principal...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2005-11-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry